Rifampicin: co-administration in 9 healthy subjects of Tracleer 125 mg twice daily for 7 days and rifampicin, a potent inducer of CYP2C9 and CYP3 A4, decreased the plasma concentrations of bosentan by 58%, and this decrease could achieve almost 90% in an individual case.